Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies

NCT01643499 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT01643499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01643499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
March 26, 2012
Completion date
July 31, 2019
Enrollment
79 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acinar cell adenocarcinoma of the pancreas, adenocarcinoma of the gallbladder, adenocarcinoma of unknown primary, adult primary cholangiocellular carcinoma, advanced adult primary liver cancer, cholangiocarcinoma of the extrahepatic bile duct, cholangiocarcinoma of the gallbladder, diffuse adenocarcinoma of the stomach, duct cell adenocarcinoma of the pancreas, intestinal adenocarcinoma of the stomach, localized unresectable adult primary liver cancer, metastatic carcinoma of unknown primary, metastatic extrahepatic bile duct cancer, mixed adenocarcinoma of the stomach, mucinous adenocarcinoma of the colon, mucinous adenocarcinoma of the rectum, newly diagnosed carcinoma of unknown primary, signet ring adenocarcinoma of the colon, signet ring adenocarcinoma of the rectum, stage iii pancreatic cancer, stage iiia colon cancer, stage iiia gallbladder cancer, stage iiia gastric cancer, stage iiia rectal cancer, stage iiib colon cancer, stage iiib gallbladder cancer, stage iiib gastric cancer, stage iiib rectal cancer, stage iiic colon cancer, stage iiic gastric cancer, stage iiic rectal cancer, stage iv gastric cancer, stage iv pancreatic cancer, stage iva colon cancer, stage iva gallbladder cancer, stage iva rectal cancer, stage ivb colon cancer, stage ivb gallbladder cancer, stage ivb rectal cancer, unresectable extrahepatic bile duct cancer